Rare Genomics Institute Leadership

Imran Babar is a Chief Business Officer at Cydan, Co-Founder & Chief Business Officer at Tiburio Therapeutics Inc, and Co-Founder and Chief Scientific Officer at Rare Genomics Institute and is based in New York City, New York. He has worked as Vice President at OrbiMed Advisors, Private Equity Senior Associate at OrbiMed Advisors, and Biotechnology Associate at Cowen and Company. Imran works or has worked at Yale University and works or has worked as floral at amber florists, Founder at Amber Flower and Gift Shop, and VP of Scientific Affairs at Rare Genomics Institute. He attended CARLETON COLLEGE between 2000 and 2004 and Yale University between 2005 and 2011.

Jimmy Lin is the President & CEO at the Rare Genomics Institute. He is also the Chief Scientific Officer at Freenome and a Venture Partner at SparkLabs Global Ventures.

Jimmy holds a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine.

Eva Wu is a Chief Program Officer at Rare Genomics Institute.

Romina Ortiz is a Chief Operating Officer at Rare Genomics Institute and is based in Los Angeles, California. She works or has worked as VP Patient Advocacy and Policy, Co-Founder at Rare Genomics Institute. Romina studied at Johns Hopkins Bloomberg School of Public Health between 2011 and 2012 and The Johns Hopkins University between 2007 and 2011.

Imran Babar is a Chief Business Officer at Cydan, Co-Founder & Chief Business Officer at Tiburio Therapeutics Inc, and Co-Founder and Chief Scientific Officer at Rare Genomics Institute and is based in New York City, New York. He has worked as Vice President at OrbiMed Advisors, Private Equity Senior Associate at OrbiMed Advisors, and Biotechnology Associate at Cowen and Company. Imran works or has worked at Yale University and works or has worked as floral at amber florists, Founder at Amber Flower and Gift Shop, and VP of Scientific Affairs at Rare Genomics Institute. He attended CARLETON COLLEGE between 2000 and 2004 and Yale University between 2005 and 2011.

Imran Babar is a Chief Business Officer at Cydan, Co-Founder & Chief Business Officer at Tiburio Therapeutics Inc, and Co-Founder and Chief Scientific Officer at Rare Genomics Institute and is based in New York City, New York. He has worked as Vice President at OrbiMed Advisors, Private Equity Senior Associate at OrbiMed Advisors, and Biotechnology Associate at Cowen and Company. Imran works or has worked at Yale University and works or has worked as floral at amber florists, Founder at Amber Flower and Gift Shop, and VP of Scientific Affairs at Rare Genomics Institute. He attended CARLETON COLLEGE between 2000 and 2004 and Yale University between 2005 and 2011.

Jimmy Lin is the President & CEO at the Rare Genomics Institute. He is also the Chief Scientific Officer at Freenome and a Venture Partner at SparkLabs Global Ventures.

Jimmy holds a PhD in Cellular and Molecular Medicine from The Johns Hopkins University School of Medicine.